{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:21:23Z","timestamp":1793042483258,"version":"4.5.0"},"reference-count":144,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Alcoholism is a global health concern. Due to its role as the principal site of\nethanol metabolism, the liver endures the most significant amount of tissue damage from\nheavy drinking. Numerous liver lesions can result from chronic and heavy alcohol use, including\nsteatosis, hepatitis, and fibrosis\/cirrhosis. Fatty liver is caused by a redox shift\nfrom the oxidized to the reduced form of nicotinamide adenine dinucleotide (NAD+)\ncaused by the ethanol oxidation reaction. The other molecular mechanisms related to the\nprogression of alcohol-induced liver injury are increasing sterol regulatory element-binding\nprotein-1 (SREBP-1) and decreasing PPAR-&amp;#945; activity, cell signaling pathway impairment,\nreactive oxygen species (ROS) accumulation, and lipid peroxidation. &lt;i&gt;Curcuma\nlonga&lt;\/i&gt; L. rhizomes contain a substance called curcumin, which is naturally yellow in color\nand is also known as turmeric yellow. Curcumin has powerful biological and pharmacological\nproperties, including antioxidant, anti-inflammatory, antifungal, antibacterial,\nantitumor, and anticancer effects. It's been employed as a hepatoprotective substance.\nCurrent studies have demonstrated the ability of curcumin to prevent the activation of\nNF-&amp;#945;B in Kupffer cells &lt;i&gt;via&lt;\/i&gt; endotoxins, to suppress the expression of various cytokines,\nchemokines, cyclooxygenase-2 (COX-2), and iNOS, as well as to modulate immune responses.\nThe present study has shown the vital role of curcumin in a variety of hepatotoxic\nprocedures, and summarizes those effects, focusing on the molecular insights they provide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867331666230815113921","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T08:57:23Z","timestamp":1692089843000},"page":"1702-1717","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Protective Effects of Curcumin against Alcoholic Fatty Liver"],"prefix":"10.2174","volume":"32","author":[{"given":"Mahdieh","family":"Khoshakhlagh","sequence":"first","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[{"name":"Research Department, Royal College of Surgeons in Ireland-Bahrain, PO Box 15503, Adliya,\nBahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[{"name":"Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences,\nMashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e6468","DOI":"10.1371\/journal.pone.0006468","volume":"4","author":"Zhao D.","year":"2009","unstructured":"Zhao D.; Chen S.; Cai J.; Guo Y.; Song Z.; Che J.; Liu C.; Wu C.; Ding M.; Deng H.; Derivation and characterization of hepatic progenitor cells from human embryonic stem cells. PLoS One  2009,4(7),e6468","journal-title":"PLoS One"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/j.jss.2011.06.032","volume":"170","author":"Yu Y.D.","year":"2011","unstructured":"Yu Y.D.; Kim K.H.; Lee S.G.; Choi S.Y.; Kim Y.C.; Byun K.S.; Cha I.H.; Park K.Y.; Cho C.H.; Choi D.H.; Hepatic differentiation from human embryonic stem cells using stromal cells. J Surg Res  2011,170(2),e253-e261","journal-title":"J Surg Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"Giannini E.G.","year":"2005","unstructured":"Giannini E.G.; Testa R.; Savarino V.; Liver enzyme alteration: A guide for clinicians. CMAJ  2005,172(3),367-379","journal-title":"CMAJ"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"14787","DOI":"10.3748\/wjg.v20.i40.14787","volume":"20","author":"Madrigal-Santill\u00e1n E.","year":"2014","unstructured":"Madrigal-Santill\u00e1n E.; Madrigal-Bujaidar E.; \u00c1lvarez-Gonz\u00e1lez I.; Sumaya-Mart\u00ednez M.T.; Guti\u00e9rrez-Salinas J.; Bautista M.; Morales-Gonz\u00e1lez \u00c1.; Garc\u00eda-Luna y Gonz\u00e1lez-Rubio M.; Aguilar-Faisal J.L.; Morales-Gonz\u00e1lez J.A.; Review of natural products with hepatoprotective effects. World J Gastroenterol  2014,20(40),14787-14804","journal-title":"World J Gastroenterol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"Wang F.S.","year":"2014","unstructured":"Wang F.S.; Fan J.G.; Zhang Z.; Gao B.; Wang H.Y.; The global burden of liver disease: The major impact of China. Hepatology  2014,60(6),2099-2108","journal-title":"Hepatology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","volume":"127","author":"Bosch F.X.","year":"2004","unstructured":"Bosch F.X.; Ribes J.; D\u00edaz M.; Cl\u00e9ries R.; Primary liver cancer: Worldwide incidence and trends. Gastroenterology  2004,127(5),S5-S16","journal-title":"Gastroenterology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"Younossi Z.M.","year":"2019","unstructured":"Younossi Z.M.; Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol  2019,70(3),531-544","journal-title":"J Hepatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-12-804274-8.00001-1","author":"Muriel P.","year":"2017","unstructured":"Muriel P.; The liver: General aspects and epidemiology. Liver Pathophysiology  2017,3-22","journal-title":"Liver Pathophysiology"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.5858\/arpa.2014-0214-RA","volume":"139","author":"Fisher K.","year":"2015","unstructured":"Fisher K.; Vuppalanchi R.; Saxena R.; Drug-induced liver injury. Arch Pathol Lab Med  2015,139(7),876-887","journal-title":"Arch Pathol Lab Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMra052270","volume":"354","author":"Navarro V.J.","year":"2006","unstructured":"Navarro V.J.; Senior J.R.; Drug-related hepatotoxicity. N Engl J Med  2006,354(7),731-739","journal-title":"N Engl J Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"172906","DOI":"10.1016\/j.pbb.2020.172906","volume":"192","author":"Lees B.","year":"2020","unstructured":"Lees B.; Meredith L.R.; Kirkland A.E.; Bryant B.E.; Squeglia L.M.; Effect of alcohol use on the adolescent brain and behavior. Pharmacol Biochem Behav  2020,192,172906","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=12","first-page":"41","volume":"38","author":"Suwanwela C.","year":"1986","unstructured":"Suwanwela C.; Poshyachinda V.; Drug abuse in Asia. Bull Narc  1986,38(1-2),41-53","journal-title":"Bull Narc"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"Angulo P.","year":"2002","unstructured":"Angulo P.; Nonalcoholic fatty liver disease. N Engl J Med  2002,346(16),1221-1231","journal-title":"N Engl J Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"Bellentani S.","year":"2000","unstructured":"Bellentani S.; Saccoccio G.; Masutti F.; Croc\u00e8 L.S.; Brandi G.; Sasso F.; Cristanini G.; Tiribelli C.; Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med  2000,132(2),112-117","journal-title":"Ann Intern Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.alcohol.2004.07.008","volume":"34","author":"Lieber C.S.","year":"2004","unstructured":"Lieber C.S.; Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol  2004,34(1),9-19","journal-title":"Alcohol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2006-960170","volume":"27","author":"de Alwis N.M.W.","year":"2007","unstructured":"de Alwis N.M.W.; Day C.P.; Genetics of alcoholic liver disease and nonalcoholic fatty liver disease. Semin Liver Dis  2007,27(1),44-54","journal-title":"Semin Liver Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/0006-291X(59)90043-9","volume":"1","author":"Lieber C.S.","year":"1959","unstructured":"Lieber C.S.; DeCarli L.M.; Schmid R.; Effect of ethanol on fatty acid metabolism in liver slices. Biochem Biophys Res Commun  1959,1(6),302-306","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1172\/JCI104266","volume":"40","author":"Lieber C.S.","year":"1961","unstructured":"Lieber C.S.; Schmid R.; The effect of ethanol on fatty acid metabolism; stimulation of hepatic fatty acid synthesis in vitro. J Clin Invest  1961,40(2),394-399","journal-title":"J Clin Invest"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/0270-9139(95)90630-4","volume":"22","author":"Niemel\u00e4 O.","year":"1995","unstructured":"Niemel\u00e4 O.; Parkkila S.; Yl\u00e4-Herttuala S.; Villanueva J.; Ruebner B.; Halsted C.H.; Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease. Hepatology  1995,22(4),1208-1212","journal-title":"Hepatology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1172\/JCI115141","volume":"87","author":"Niemel\u00e4 O.","year":"1991","unstructured":"Niemel\u00e4 O.; Juvonen T.; Parkkila S.; Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest  1991,87(4),1367-1374","journal-title":"J Clin Invest"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1073\/pnas.83.20.7923","volume":"83","author":"Israel Y.","year":"1986","unstructured":"Israel Y.; Hurwitz E.; Niemel\u00e4 O.; Arnon R.; Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci  1986,83(20),7923-7927","journal-title":"Proc Natl Acad Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/j.1530-0277.2000.tb04656.x","volume":"24","author":"Viitala K.","year":"2000","unstructured":"Viitala K.; Makkonen K.; Israel Y.; Lehtim\u00e4ki T.; Jaakkola O.; Koivula T.; Blake J.E.; Niemel\u00e4 O.; Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers. Alcohol Clin Exp Res  2000,24(7),1103-1109","journal-title":"Alcohol Clin Exp Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/1874467214666210412144416","volume":"15","author":"Tang W.C.","year":"2022","unstructured":"Tang W.C.; Chang Y.W.; Che M.; Wang M.H.; Lai K.K.; Fueger P.T.; Huang W.; Lin S.B.; Lai K.K.Y.; Thioacetamide-induced norepinephrine production by hepatocytes is associated with hepatic stellate cell activation and liver fibrosis. Curr Mol Pharmacol  2022,15(2),454-461","journal-title":"Curr Mol Pharmacol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1152\/physrev.1979.59.3.527","volume":"59","author":"Chance B.","year":"1979","unstructured":"Chance B.; Sies H.; Boveris A.; Hydroperoxide metabolism in mammalian organs. Physiol Rev  1979,59(3),527-605","journal-title":"Physiol Rev"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-76-2-326","volume":"76","author":"LIEBER CS.","year":"1972","unstructured":"LIEBER CS.; Metabolism of ethanol and alcoholism: Racial and acquired factors. Ann Intern Med  1972,76(2),326-327","journal-title":"Ann Intern Med"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0022-3565(25)29204-7","volume":"181","author":"Lieber C.S.","year":"1972","unstructured":"Lieber C.S.; DeCarli L.M.; The role of the hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo. J Pharmacol Exp Ther  1972,181(2),279-287","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1152\/physrev.1997.77.2.517","volume":"77","author":"Lieber C.S.","year":"1997","unstructured":"Lieber C.S.; Cytochrome P-4502E1: Its physiological and pathological role. Physiol Rev  1997,77(2),517-544","journal-title":"Physiol Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0306-4522(90)90154-V","volume":"34","author":"Hansson T.","year":"1990","unstructured":"Hansson T.; Tindberg N.; Ingelman-Sundberg M.; Ko\u00a8hler C.; Regional distribution of ethanol-inducible cytochrome P450 IIE1 in the rat central nervous system. Neuroscience  1990,34(2),451-463","journal-title":"Neuroscience"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0026-895X(25)08567-0","volume":"47","author":"De Waziers I.","year":"1995","unstructured":"De Waziers I.; Garlatti M.; Bouguet J.; Beaune P.H.; Barouki R.; Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line. Mol Pharmacol  1995,47(3),474-479","journal-title":"Mol Pharmacol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0026-895X(24)13076-3","volume":"54","author":"Peng H-M.","year":"1998","unstructured":"Peng H-M.; Coon M.J.; Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone. Mol Pharmacol  1998,54(4),740-747","journal-title":"Mol Pharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0006-291X(91)91427-E","volume":"179","author":"Terelius Y.","year":"1991","unstructured":"Terelius Y.; Norsten-H\u00f6g C.; Cronholm T.; Ingelman-Sundberg M.; Acetaldehyde as a substrate for ethanol-inducible cytochrome P450 (CYP2E1). Biochem Biophys Res Commun  1991,179(1),689-694","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S1359-6446(00)01511-7","volume":"5","author":"Harvey A.","year":"2000","unstructured":"Harvey A.; Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today  2000,5(7),294-300","journal-title":"Drug Discov Today"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12094-007-0138-9","volume":"9","author":"Gordaliza M.","year":"2007","unstructured":"Gordaliza M.; Natural products as leads to anticancer drugs. Clin Transl Oncol  2007,9(12),767-776","journal-title":"Clin Transl Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ejmech.2012.12.062","volume":"63","author":"Zhang A.","year":"2013","unstructured":"Zhang A.; Sun H.; Wang X.; Recent advances in natural products from plants for treatment of liver diseases. Eur J Med Chem  2013,63,570-577","journal-title":"Eur J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/2225-4110.110411","volume":"3","author":"Xiao J.","year":"2013","unstructured":"Xiao J.; So K.F.; Liong E.C.; Tipoe G.L.; Recent advances in the herbal treatment of non-alcoholic Fatty liver disease. J Tradit Complement Med  2013,3(2),88-94","journal-title":"J Tradit Complement Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2174\/138920112799095310","volume":"13","author":"Kim M.S.","year":"2012","unstructured":"Kim M.S.; Kung S.; Grewal T.; Roufogalis B.D.; Methodologies for investigating natural medicines for the treatment of nonalcoholic fatty liver disease (NAFLD). Curr Pharm Biotechnol  2012,13(2),278-291","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.abb.2009.02.013","volume":"485","author":"Pullakhandam R.","year":"2009","unstructured":"Pullakhandam R.; Srinivas P.N.B.S.; Nair M.K.; Reddy G.B.; Binding and stabilization of transthyretin by curcumin. Arch Biochem Biophys  2009,485(2),115-119","journal-title":"Arch Biochem Biophys"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.fct.2011.10.070","volume":"50","author":"Martin R.C.G.","year":"2012","unstructured":"Martin R.C.G.; Aiyer H.S.; Malik D.; Li Y.; Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs. curcumin: Similar root but different effects. Food Chem Toxicol  2012,50(2),227-231","journal-title":"Food Chem Toxicol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1158\/0008-5472.CAN-06-3066","volume":"67","author":"Li M.","year":"2007","unstructured":"Li M.; Zhang Z.; Hill D.L.; Wang H.; Zhang R.; Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K\/mTOR\/ETS2 pathway. Cancer Res  2007,67(5),1988-1996","journal-title":"Cancer Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/biof.1079","volume":"39","author":"Gupta S.C.","year":"2013","unstructured":"Gupta S.C.; Kismali G.; Aggarwal B.B.; Curcumin, a component of turmeric: From farm to pharmacy. Biofactors  2013,39(1),2-13","journal-title":"Biofactors"},{"key":"ref=41","first-page":"1","volume":"1","author":"Bagchi A.","year":"2012","unstructured":"Bagchi A.; Extraction of curcumin IOSR journal of environmental science. Toxicol Food Tech  2012,1(3),1-16","journal-title":"Toxicol Food Tech"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1358\/dof.2010.35.2.1426640","volume":"35","author":"Shehzad A.","year":"2010","unstructured":"Shehzad A.; Lee Y.S.; Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review. Drugs Future  2010,35(2),113","journal-title":"Drugs Future"},{"key":"ref=43","first-page":"363","volume":"23","author":"Aggarwal B.B.","year":"2003","unstructured":"Aggarwal B.B.; Kumar A.; Bharti A.C.; Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res  2003,23(1A),363-98","journal-title":"Anticancer Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"Goel A.","year":"2008","unstructured":"Goel A.; Kunnumakkara A.B.; Aggarwal B.B.; Curcumin as \u201cCurecumin\u201d: From kitchen to clinic. Biochem Pharmacol  2008,75(4),787-809","journal-title":"Biochem Pharmacol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/carcin\/16.10.2493","volume":"16","author":"Huang M.T.","year":"1995","unstructured":"Huang M.T.; Ma W.; Lu Y.P.; Chang R.L.; Fisher C.; Manchand P.S.; Newmark H.L.; Conney A.H.; You M.; Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetateinduced tumor promotion. Carcinogenesis  1995,16(10),2493-2497","journal-title":"Carcinogenesis"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jhep.2004.08.010","volume":"41","author":"Leclercq I.A.","year":"2004","unstructured":"Leclercq I.A.; Farrell G.C.; Sempoux C.; Pe\u00f1a A.; Horsmans Y.; Curcumin inhibits NF-\u03baB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol  2004,41(6),926-934","journal-title":"J Hepatol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0009-2797(99)00096-4","volume":"121","author":"Ahsan H.","year":"1999","unstructured":"Ahsan H.; Parveen N.; Khan N.U.; Hadi S.M.; Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact  1999,121(2),161-175","journal-title":"Chem Biol Interact"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejphar.2016.11.038","volume":"796","author":"Bonfanti R.","year":"2017","unstructured":"Bonfanti R.; Musumeci T.; Russo C.; Pellitteri R.; The protective effect of curcumin in Olfactory Ensheathing Cells exposed to hypoxia. Eur J Pharmacol  2017,796,62-68","journal-title":"Eur J Pharmacol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1440-1681.2011.05648.x","volume":"39","author":"Gupta S.C.","year":"2012","unstructured":"Gupta S.C.; Patchva S.; Koh W.; Aggarwal B.B.; Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol  2012,39(3),283-299","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/ptr.7350","volume":"36","author":"Heidari Z.","year":"2022","unstructured":"Heidari Z.; Daei M.; Boozari M.; Jamialahmadi T.; Sahebkar A.; Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence. Phytother Res  2022,36(4),1442-1458","journal-title":"Phytother Res"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"113621","DOI":"10.1016\/j.biopha.2022.113621","volume":"154","author":"Khayatan D.","year":"2022","unstructured":"Khayatan D.; Razavi S.M.; Arab Z.N.; Niknejad A.H.; Nouri K.; Momtaz S.; Gumpricht E.; Jamialahmadi T.; Abdolghaffari A.H.; Barreto G.E.; Sahebkar A.; Protective effects of curcumin against traumatic brain injury. Biomed Pharmacother  2022,154,113621","journal-title":"Biomed Pharmacother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/jcp.26848","volume":"234","author":"Mokhtari-Zaer A.","year":"2019","unstructured":"Mokhtari-Zaer A.; Marefati N.; Atkin S.L.; Butler A.E.; Sahebkar A.; The protective role of curcumin in myocardial ischemia\u2013reperfusion injury. J Cell Physiol  2019,234(1),214-222","journal-title":"J Cell Physiol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.2174\/1381612822666160527113501","volume":"22","author":"Abbas Momtazi A.","year":"2016","unstructured":"Abbas Momtazi A.; Sahebkar A.; Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr Pharm Des  2016,22(28),4386-4397","journal-title":"Curr Pharm Des"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.phrs.2018.09.012","volume":"136","author":"Parsamanesh N.","year":"2018","unstructured":"Parsamanesh N.; Moossavi M.; Bahrami A.; Butler A.E.; Sahebkar A.; Therapeutic potential of curcumin in diabetic complications. Pharmacol Res  2018,136,181-193","journal-title":"Pharmacol Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.fertnstert.2010.07.1071","volume":"94","author":"Sahebkar A.","year":"2010","unstructured":"Sahebkar A.; Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril  2010,94(5),e75-e76","journal-title":"Fertil Steril"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.virusres.2016.10.020","volume":"228","author":"Fehl D.J.","year":"2017","unstructured":"Fehl D.J.; Ahmed M.; Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers. Virus Res  2017,228,14-23","journal-title":"Virus Res"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brainres.2016.03.010","volume":"1642","author":"Chang X.-R.","year":"2016","unstructured":"Chang X.-R.; Wang L.; Li J.; Wu D.-S.; Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats. Brain Res  2016,1642,219-25","journal-title":"Brain Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2013.02.012","volume":"704","author":"Choudhary K.M.","year":"2013","unstructured":"Choudhary K.M.; Mishra A.; Poroikov V.V.; Goel R.K.; Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. Eur J Pharmacol  2013,704(1-3),33-40","journal-title":"Eur J Pharmacol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.archoralbio.2012.10.011","volume":"58","author":"Andrade M.C.","year":"2013","unstructured":"Andrade M.C.; Ribeiro A.P.D.; Dovigo L.N.; Brunetti I.L.; Giampaolo E.T.; Bagnato V.S.; Pavarina A.C.; Effect of different pre-irradiation times on curcumin-mediated photodynamic therapy against planktonic cultures and biofilms of Candida spp. Arch Oral Biol  2013,58(2),200-210","journal-title":"Arch Oral Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biopha.2016.12.105","volume":"87","author":"Samarghandian S.","year":"2017","unstructured":"Samarghandian S.; Azimi-Nezhad M.; Farkhondeh T.; Samini F.; Anti-oxidative effects of curcumin on immobilization-induced oxidative stress in rat brain, liver and kidney. Biomed Pharmacother  2017,87,223-229","journal-title":"Biomed Pharmacother"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jamcollsurg.2005.02.030","volume":"200","author":"Chai H.","year":"2005","unstructured":"Chai H.; Yan S.; Lin P.; Lumsden A.B.; Yao Q.; Chen C.; Curcumin blocks HIV protease inhibitor ritonavir-induced vascular dysfunction in porcine coronary arteries. J Am Coll Surg  2005,200(6),820-830","journal-title":"J Am Coll Surg"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.febslet.2009.12.019","volume":"584","author":"Kim K.","year":"2010","unstructured":"Kim K.; Kim K.H.; Kim H.Y.; Cho H.K.; Sakamoto N.; Cheong J.; Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett  2010,584(4),707-712","journal-title":"FEBS Lett"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.virol.2007.11.028","volume":"373","author":"Kutluay S.B.","year":"2008","unstructured":"Kutluay S.B.; Doroghazi J.; Roemer M.E.; Triezenberg S.J.; Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300\/CBP histone acetyltransferase activity. Virology  2008,373(2),239-247","journal-title":"Virology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.foodchem.2009.09.011","volume":"119","author":"Chen D.Y.","year":"2010","unstructured":"Chen D.Y.; Shien J.H.; Tiley L.; Chiou S.S.; Wang S.Y.; Chang T.J.; Lee Y-J.; Chan K-W.; Hsu W-L.; Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem  2010,119(4),1346-1351","journal-title":"Food Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ijc.20668","volume":"113","author":"Prusty B.K.","year":"2005","unstructured":"Prusty B.K.; Das B.C.; Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer  2005,113(6),951-960","journal-title":"Int J Cancer"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s10620-005-3032-8","volume":"50","author":"Holt P.R.","year":"2005","unstructured":"Holt P.R.; Katz S.; Kirshoff R.; Curcumin therapy in inflammatory bowel disease: A pilot study. Dig Dis Sci  2005,50(11),2191-2193","journal-title":"Dig Dis Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1039\/C5FO00485C","volume":"6","author":"Prasad S.","year":"2015","unstructured":"Prasad S.; Tyagi A.K.; Curcumin and its analogues: A potential natural compound against HIV infection and AIDS. Food Funct  2015,6(11),3412-3419","journal-title":"Food Funct"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1021\/cn200088r","volume":"2","author":"Dolai S.","year":"2011","unstructured":"Dolai S.; Shi W.; Corbo C.; Sun C.; Averick S.; Obeysekera D.; Farid M.; Alonso A.; Banerjee P.; Raja K.; \u201cClicked\u201d sugar-curcumin conjugate: Modulator of amyloid-\u03b2 and tau peptide aggregation at ultralow concentrations. ACS Chem Neurosci  2011,2(12),694-699","journal-title":"ACS Chem Neurosci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"104921","DOI":"10.1016\/j.phrs.2020.104921","volume":"159","author":"Hasanzadeh S.","year":"2020","unstructured":"Hasanzadeh S.; Read M.I.; Bland A.R.; Majeed M.; Jamialahmadi T.; Sahebkar A.; Curcumin: An inflammasome silencer. Pharmacol Res  2020,159,104921","journal-title":"Pharmacol Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","volume":"17","author":"Momtazi-Borojeni A.A.","year":"2018","unstructured":"Momtazi-Borojeni A.A.; Haftcheshmeh S.M.; Esmaeili S.A.; Johnston T.P.; Abdollahi E.; Sahebkar A.; Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev  2018,17(2),125-135","journal-title":"Autoimmun Rev"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.2147\/DDDT.S327378","volume":"15","author":"Peng Y.","year":"2021","unstructured":"Peng Y.; Ao M.; Dong B.; Jiang Y.; Yu L.; Chen Z.; Hu C.; Xu R.; Anti-inflammatory effects of curcumin in the inflammatory diseases: Status, limitations and countermeasures. Drug Des Devel Ther  2021,15,4503-4525","journal-title":"Drug Des Devel Ther"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.bcp.2008.08.008","volume":"76","author":"Anand P.","year":"2008","unstructured":"Anand P.; Thomas S.G.; Kunnumakkara A.B.; Sundaram C.; Harikumar K.B.; Sung B.; Tharakan S.T.; Misra K.; Priyadarsini I.K.; Rajasekharan K.N.; Aggarwal B.B.; Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol  2008,76(11),1590-1611","journal-title":"Biochem Pharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0006-2952(00)00489-5","volume":"60","author":"Pan M.H.","year":"2000","unstructured":"Pan M.H.; Lin-Shiau S.Y.; Lin J.K.; Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of I\u03baB kinase and NF\u03baB activation in macrophages. Biochem Pharmacol  2000,60(11),1665-1676","journal-title":"Biochem Pharmacol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jnutbio.2012.03.012","volume":"24","author":"Pan Y.","year":"2013","unstructured":"Pan Y.; Zhu G.; Wang Y.; Cai L.; Cai Y.; Hu J.; Li Y.; Yan Y.; Wang Z.; Li X.; Wei T.; Liang G.; Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart. J Nutr Biochem  2013,24(1),146-155","journal-title":"J Nutr Biochem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.coph.2007.03.002","volume":"7","author":"Khanna D.","year":"2007","unstructured":"Khanna D.; Sethi G.; Ahn K.; Pandey M.; Kunnumakkara A.; Sung B.; Aggarwal A.; Aggarwal B.; Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol  2007,7(3),344-351","journal-title":"Curr Opin Pharmacol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s10495-008-0221-x","volume":"13","author":"Bakhshi J.","year":"2008","unstructured":"Bakhshi J.; Weinstein L.; Poksay K.S.; Nishinaga B.; Bredesen D.E.; Rao R.V.; Coupling endoplasmic reticulum stress to the cell death program in mouse melanoma cells: Effect of curcumin. Apoptosis  2008,13(7),904-914","journal-title":"Apoptosis"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-06-4257","volume":"67","author":"Kunnumakkara A.B.","year":"2007","unstructured":"Kunnumakkara A.B.; Guha S.; Krishnan S.; Diagaradjane P.; Gelovani J.; Aggarwal B.B.; Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res  2007,67(8),3853-3861","journal-title":"Cancer Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/carcin\/13.11.2183","volume":"13","author":"Huang M.T.","year":"1992","unstructured":"Huang M.T.; Wang Z.Y.; Georgiadis C.A.; Laskin J.D.; Conney A.H.; Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis  1992,13(11),2183-2186","journal-title":"Carcinogenesis"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.critrevonc.2017.12.005","volume":"122","author":"Mohajeri M.","year":"2018","unstructured":"Mohajeri M.; Sahebkar A.; Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review. Crit Rev Oncol Hematol  2018,122,30-51","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-540-79116-4_7","author":"Sethi G.","year":"2009","unstructured":"Sethi G.; Sung B.; Aggarwal B.B.; The role of curcumin in modern medicine. Herbal Drugs: Ethnomedicine to Modern Medicine  2009,97-113","journal-title":"Herbal Drugs: Ethnomedicine to Modern Medicine"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/1078-0432.CCR-08-2791","volume":"15","author":"Angelo L.S.","year":"2009","unstructured":"Angelo L.S.; Kurzrock R.; Turmeric and green tea: A recipe for the treatment of B-chronic lymphocytic leukemia. Clin Cancer Res  2009,15(4),1123-1125","journal-title":"Clin Cancer Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jcb.10638","volume":"90","author":"Chan W.H.","year":"2003","unstructured":"Chan W.H.; Wu C.C.; Yu J.S.; Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J Cell Biochem  2003,90(2),327-338","journal-title":"J Cell Biochem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.phymed.2009.04.008","volume":"16","author":"Liu Q.","year":"2009","unstructured":"Liu Q.; Loo W.T.Y.; Sze S.C.W.; Tong Y.; Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NF\u03baB, cyclinD and MMP-1 transcription. Phytomedicine  2009,16(10),916-922","journal-title":"Phytomedicine"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1208\/s12248-009-9128-x","volume":"11","author":"Ravindran J.","year":"2009","unstructured":"Ravindran J.; Prasad S.; Aggarwal B.B.; Curcumin and cancer cells: How many ways can curry kill tumor cells selectively? AAPS J  2009,11(3),495-510","journal-title":"AAPS J"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1476-5381.2009.00261.x","volume":"157","author":"Kang Q.","year":"2009","unstructured":"Kang Q.; Chen A.; Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells. Br J Pharmacol  2009,157(8),1354-1367","journal-title":"Br J Pharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/sj.bjp.0701914","volume":"124","author":"Chen H.W.","year":"1998","unstructured":"Chen H.W.; Huang H.C.; Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Br J Pharmacol  1998,124(6),1029-1040","journal-title":"Br J Pharmacol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10661-010-1736-5","volume":"179","author":"Ahmed T.","year":"2011","unstructured":"Ahmed T.; Pathak R.; Mustafa M.; Kar R.; Tripathi A.K.; Ahmed R.S.; Banerjee B.D.; Ameliorating effect of N-acetylcysteine and curcumin on pesticide-induced oxidative DNA damage in human peripheral blood mononuclear cells. Environ Monit Assess  2011,179(1-4),293-299","journal-title":"Environ Monit Assess"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ptr.5045","volume":"28","author":"Sahebkar A.","year":"2014","unstructured":"Sahebkar A.; Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res  2014,28(5),633-642","journal-title":"Phytother Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/j.1476-5381.2012.02109.x","volume":"167","author":"Wang N.P.","year":"2012","unstructured":"Wang N.P.; Wang Z.F.; Tootle S.; Philip T.; Zhao Z.Q.; Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction. Br J Pharmacol  2012,167(7),1550-1562","journal-title":"Br J Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0006-2952(99)00206-3","volume":"58","author":"Shah B.H.","year":"1999","unstructured":"Shah B.H.; Nawaz Z.; Pertani S.A.; Roomi A.; Mahmood H.; Saeed S.A.; Gilani A.H.; Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca signaling. Biochem Pharmacol  1999,58(7),1167-1172","journal-title":"Biochem Pharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/0253-7613.91871","volume":"44","author":"Swamy A.","year":"2012","unstructured":"Swamy A.; Gulliaya S.; Thippeswamy A.; Koti B.; Manjula D.; Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol  2012,44(1),73-77","journal-title":"Indian J Pharmacol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1570159X11311040002","volume":"11","author":"Lee W.H.","year":"2013","unstructured":"Lee W.H.; Loo C.Y.; Bebawy M.; Luk F.; Mason R.; Rohanizadeh R.; Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol  2013,11(4),338-378","journal-title":"Curr Neuropharmacol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","volume":"21","author":"Lim G.P.","year":"2001","unstructured":"Lim G.P.; Chu T.; Yang F.; Beech W.; Frautschy S.A.; Cole G.M.; The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci  2001,21(21),8370-8377","journal-title":"J Neurosci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/jcp.0b013e318160862c","volume":"28","author":"Baum L.","year":"2008","unstructured":"Baum L.; Lam C.W.K.; Cheung S.K.K.; Kwok T.; Lui V.; Tsoh J.; Lam L.; Leung V.; Hui E.; Ng C.; Woo J.; Chiu H.F.K.; Goggins W.B.; Zee B.C.Y.; Cheng K.F.; Fong C.Y.S.; Wong A.; Mok H.; Chow M.S.S.; Ho P.C.; Ip S.P.; Ho C.S.; Yu X.W.; Lai C.Y.L.; Chan M.H.; Szeto S.; Chan I.H.S.; Mok V.; Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol  2008,28(1),110-113","journal-title":"J Clin Psychopharmacol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"Yang F.","year":"2005","unstructured":"Yang F.; Lim G.P.; Begum A.N.; Ubeda O.J.; Simmons M.R.; Ambegaokar S.S.; Chen P.P.; Kayed R.; Glabe C.G.; Frautschy S.A.; Cole G.M.; Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem  2005,280(7),5892-5901","journal-title":"J Biol Chem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0304-3940(01)01677-9","volume":"303","author":"Kim D.S.H.L.","year":"2001","unstructured":"Kim D.S.H.L.; Park S.Y.; Kim J.Y.; Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from \u03b2A(1\u201342) insult. Neurosci Lett  2001,303(1),57-61","journal-title":"Neurosci Lett"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/A:1013106527829","volume":"57","author":"Arun N.","year":"2002","unstructured":"Arun N.; Nalini N.; Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr  2002,57(1),41-52","journal-title":"Plant Foods Hum Nutr"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejphar.2007.08.001","volume":"576","author":"Kuhad A.","year":"2007","unstructured":"Kuhad A.; Chopra K.; Curcumin attenuates diabetic encephalopathy in rats: Behavioral and biochemical evidences. Eur J Pharmacol  2007,576(1-3),34-42","journal-title":"Eur J Pharmacol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00024382-200205000-00010","volume":"17","author":"Lukita-Atmadja W.","year":"2002","unstructured":"Lukita-Atmadja W.; Ito Y.; Baker G.L.; McCuskey R.S.; Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock  2002,17(5),399-403","journal-title":"Shock"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.fitote.2011.04.003","volume":"82","author":"\u010cern\u00fd D.","year":"2011","unstructured":"\u010cern\u00fd D.; Leki\u0107 N.; V\u00e1\u0148ov\u00e1 K.; Muchov\u00e1 L.; Ho\u0159\u00ednek A.; Kmon\u00ed\u010dkov\u00e1 E.; Z\u00eddek Z.; Kamen\u00edkov\u00e1 L.; Farghali H.; Hepatoprotective effect of curcumin in lipopolysaccharide\/-galactosamine model of liver injury in rats: Relationship to HO-1\/CO antioxidant system. Fitoterapia  2011,82(5),786-791","journal-title":"Fitoterapia"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","volume":"291","author":"Mokdad A.H.","year":"2004","unstructured":"Mokdad A.H.; Marks J.S.; Stroup D.F.; Gerberding J.L.; Actual causes of death in the United States, 2000. JAMA  2004,291(10),1238-1245","journal-title":"JAMA"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","volume":"372","author":"Thursz M.R.","year":"2015","unstructured":"Thursz M.R.; Richardson P.; Allison M.; Austin A.; Bowers M.; Day C.P.; Downs N.; Gleeson D.; MacGilchrist A.; Grant A.; Hood S.; Masson S.; McCune A.; Mellor J.; O\u2019Grady J.; Patch D.; Ratcliffe I.; Roderick P.; Stanton L.; Vergis N.; Wright M.; Ryder S.; Forrest E.H.; Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med  2015,372(17),1619-1628","journal-title":"N Engl J Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.23258","volume":"51","author":"O\u2019Shea R.S.","year":"2010","unstructured":"O\u2019Shea R.S.; Dasarathy S.; McCullough A.J.; Alcoholic liver disease. Hepatology  2010,51(1),307-328","journal-title":"Hepatology"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"11684","DOI":"10.3748\/wjg.v20.i33.11684","volume":"20","author":"Torruellas C.","year":"2014","unstructured":"Torruellas C.; French S.W.; Medici V.; Diagnosis of alcoholic liver disease. World J Gastroenterol  2014,20(33),11684-11699","journal-title":"World J Gastroenterol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","volume":"147","author":"Yeh M.M.","year":"2014","unstructured":"Yeh M.M.; Brunt E.M.; Pathological features of fatty liver disease. Gastroenterology  2014,147(4),754-764","journal-title":"Gastroenterology"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1111\/j.1440-1746.2006.04582.x","volume":"21","author":"Crabb D.W.","year":"2006","unstructured":"Crabb D.W.; Liangpunsakul S.; Alcohol and lipid metabolism. J Gastroenterol Hepatol  2006,21(s3),S56-S60","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1566524033479537","volume":"3","author":"Yu S.","year":"2003","unstructured":"Yu S.; Rao S.; Reddy J.K.; Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med  2003,3(6),561-572","journal-title":"Curr Mol Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1074\/jbc.M008791200","volume":"276","author":"Galli A.","year":"2001","unstructured":"Galli A.; Pinaire J.; Fischer M.; Dorris R.; Crabb D.W.; The transcriptional and DNA binding activity of peroxisome proliferator-activated receptor alpha is inhibited by ethanol metabolism. A novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem  2001,276(1),68-75","journal-title":"J Biol Chem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","volume":"75","author":"Hardwick J.P.","year":"2008","unstructured":"Hardwick J.P.; Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol  2008,75(12),2263-2275","journal-title":"Biochem Pharmacol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1074\/jbc.273.10.5678","volume":"273","author":"Aoyama T.","year":"1998","unstructured":"Aoyama T.; Peters J.M.; Iritani N.; Nakajima T.; Furihata K.; Hashimoto T.; Gonzalez F.J.; Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem  1998,273(10),5678-5684","journal-title":"J Biol Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"29342","DOI":"10.1074\/jbc.M202411200","volume":"277","author":"You M.","year":"2002","unstructured":"You M.; Fischer M.; Deeg M.A.; Crabb D.W.; Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem  2002,277(32),29342-29347","journal-title":"J Biol Chem"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.tox.2013.09.009","volume":"314","author":"Wang T.","year":"2013","unstructured":"Wang T.; Yang P.; Zhan Y.; Xia L.; Hua Z.; Zhang J.; Deletion of circadian gene Per1 alleviates acute ethanol-induced hepatotoxicity in mice. Toxicology  2013,314(2-3),193-201","journal-title":"Toxicology"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.biocel.2012.10.002","volume":"45","author":"Thomes P.G.","year":"2013","unstructured":"Thomes P.G.; Osna N.A.; Davis J.S.; Donohue T.M.; Cellular steatosis in ethanol oxidizing-HepG2 cells is partially controlled by the transcription factor, early growth response-1. Int J Biochem Cell Biol  2013,45(2),454-463","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.biocel.2012.02.016","volume":"44","author":"Sharara-Chami R.I.","year":"2012","unstructured":"Sharara-Chami R.I.; Zhou Y.; Ebert S.; Pacak K.; Ozcan U.; Majzoub J.A.; Epinephrine deficiency results in intact glucose counter-regulation, severe hepatic steatosis and possible defective autophagy in fasting mice. Int J Biochem Cell Biol  2012,44(6),905-913","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/207594","volume":"2012","author":"Galligan J.J.","year":"2012","unstructured":"Galligan J.J.; Smathers R.L.; Shearn C.T.; Fritz K.S.; Backos D.S.; Jiang H.; Franklin C.C.; Orlicky D.J.; MacLean K.N.; Petersen D.R.; Oxidative stress and the ER stress response in a murine model for early-stage alcoholic liver disease. J Toxicol  2012,2012,1-12","journal-title":"J Toxicol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.freeradbiomed.2012.06.029","volume":"53","author":"Yang L.","year":"2012","unstructured":"Yang L.; Wu D.; Wang X.; Cederbaum A.I.; Cytochrome P4502E1, oxidative stress, JNK, and autophagy in acute alcohol-induced fatty liver. Free Radic Biol Med  2012,53(5),1170-1180","journal-title":"Free Radic Biol Med"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/S0016-5085(03)00276-2","volume":"124","author":"Ji C.","year":"2003","unstructured":"Ji C.; Kaplowitz N.; Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology  2003,124(5),1488-1499","journal-title":"Gastroenterology"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1053\/j.gastro.2004.09.049","volume":"127","author":"You M.","year":"2004","unstructured":"You M.; Matsumoto M.; Pacold C.M.; Cho W.K.; Crabb D.W.; The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology  2004,127(6),1798-1808","journal-title":"Gastroenterology"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI29044","volume":"116","author":"Long Y.C.","year":"2006","unstructured":"Long Y.C.; Zierath J.R.; AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest  2006,116(7),1776-1783","journal-title":"J Clin Invest"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bbrc.2008.03.005","volume":"370","author":"Lieber C.S.","year":"2008","unstructured":"Lieber C.S.; Leo M.A.; Wang X.; DeCarli L.M.; Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1\u03b1 in rats. Biochem Biophys Res Commun  2008,370(1),44-48","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jhep.2011.07.024","volume":"56","author":"Nishiyama Y.","year":"2012","unstructured":"Nishiyama Y.; Goda N.; Kanai M.; Niwa D.; Osanai K.; Yamamoto Y.; Senoo-Matsuda N.; Johnson R.S.; Miura S.; Kabe Y.; Suematsu M.; HIF-1\u03b1 induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice. J Hepatol  2012,56(2),441-447","journal-title":"J Hepatol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","volume":"132","author":"Colmenero J.","year":"2007","unstructured":"Colmenero J.; Bataller R.; Sancho-Bru P.; Bellot P.; Miquel R.; Moreno M.; Jares P.; Bosch J.; Arroyo V.; Caballer\u00eda J.; Gin\u00e8s P.; Hepatic expression of candidate genes in patients with alcoholic hepatitis: Correlation with disease severity. Gastroenterology  2007,132(2),687-697","journal-title":"Gastroenterology"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"Xu A.","year":"2003","unstructured":"Xu A.; Wang Y.; Keshaw H.; Xu L.Y.; Lam K.S.L.; Cooper G.J.S.; The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest  2003,112(1),91-100","journal-title":"J Clin Invest"},{"key":"ref=124","first-page":"18","volume":"17","author":"Dehkordi F.R.","year":"2012","unstructured":"Dehkordi F.R.; Roghani M.; Baluchnejadmojarad T.; The effect of curcumin on serum level of aspartate and alanine amoinotransferase and cardiac level of oxidative stress markers in diabetic rats. Pajoohandeh J  2012,17(1),18-25","journal-title":"Pajoohandeh J"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"G321","DOI":"10.1152\/ajpgi.00230.2002","volume":"284","author":"Nanji A.A.","year":"2003","unstructured":"Nanji A.A.; Jokelainen K.; Tipoe G.L.; Rahemtulla A.; Thomas P.; Dannenberg A.J.; Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-\u03baB-dependent genes. Am J Physiol Gastrointest Liver Physiol  2003,284(2),G321-G327","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.lfs.2013.09.014","volume":"93","author":"Lee H.I.","year":"2013","unstructured":"Lee H.I.; McGregor R.A.; Choi M.S.; Seo K.I.; Jung U.J.; Yeo J.; Kim M.J.; Lee M.K.; Low doses of curcumin protect alcohol-induced liver damage by modulation of the alcohol metabolic pathway, CYP2E1 and AMPK. Life Sci  2013,93(18-19),693-699","journal-title":"Life Sci"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.phymed.2011.12.006","volume":"19","author":"Rong S.","year":"2012","unstructured":"Rong S.; Zhao Y.; Bao W.; Xiao X.; Wang D.; Nussler A.K.; Yan H.; Yao P.; Liu L.; Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity. Phytomedicine  2012,19(6),545-550","journal-title":"Phytomedicine"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4103\/0973-1296.165556","volume":"11","author":"Dong W.G.","year":"2015","unstructured":"Dong W.G.; Xiong Z.E.; Wang B.; Tong Q.; Li Z.; Curcumin attenuates chronic ethanol-induced liver injury by inhibition of oxidative stress via mitogen-activated protein kinase\/nuclear factor E2-related factor 2 pathway in mice. Pharmacogn Mag  2015,11(44),707-715","journal-title":"Pharmacogn Mag"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/5017460","volume":"2016","author":"Varatharajalu R.","year":"2016","unstructured":"Varatharajalu R.; Garige M.; Leckey L.C.; Reyes-Gordillo K.; Shah R.; Lakshman M.R.; Protective role of dietary curcumin in the prevention of the oxidative stress induced by chronic alcohol with respect to hepatic injury and antiatherogenic markers. Oxid Med Cell Longev  2016,2016,1-10","journal-title":"Oxid Med Cell Longev"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/iub.1409","volume":"67","author":"Lu C.","year":"2015","unstructured":"Lu C.; Zhang F.; Xu W.; Wu X.; Lian N.; Jin H.; Chen Q.; Chen L.; Shao J.; Wu L.; Lu Y.; Zheng S.; Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2\/FXR signaling in hepatocytes. IUBMB Life  2015,67(8),645-658","journal-title":"IUBMB Life"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2017.05.001","volume":"328","author":"Guo C.","year":"2017","unstructured":"Guo C.; Ma J.; Zhong Q.; Zhao M.; Hu T.; Chen T.; Qiu L.; Wen L.; Curcumin improves alcoholic fatty liver by inhibiting fatty acid biosynthesis. Toxicol Appl Pharmacol  2017,328,1-9","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/hep.510300402","volume":"30","author":"Nanji A.A.","year":"1999","unstructured":"Nanji A.A.; Jokelainen K.; Rahemtulla A.; Miao L.; Fogt F.; Matsumoto H.; Tahan S.R.; Su G.L.; Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology  1999,30(4),934-943","journal-title":"Hepatology"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/labinvest.2011.86","volume":"91","author":"Bisht S.","year":"2011","unstructured":"Bisht S.; Khan M.A.; Bekhit M.; Bai H.; Cornish T.; Mizuma M.; Rudek M.A.; Zhao M.; Maitra A.; Ray B.; Lahiri D.; Maitra A.; Anders R.A.; A polymeric nanoparticle formulation of curcumin (NanoCurc\u2122) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest  2011,91(9),1383-1395","journal-title":"Lab Invest"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ijpara.2010.12.011","volume":"41","author":"Charoensuk L.","year":"2011","unstructured":"Charoensuk L.; Pinlaor P.; Prakobwong S.; Hiraku Y.; Laothong U.; Ruangjirachuporn W.; Yongvanit P.; Pinlaor S.; Curcumin induces a nuclear factor-erythroid 2-related factor 2-driven response against oxidative and nitrative stress after praziquantel treatment in liver fluke-infected hamsters. Int J Parasitol  2011,41(6),615-626","journal-title":"Int J Parasitol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1665-2681(19)31521-2","volume":"10","author":"Bassiouny A.R.","year":"2011","unstructured":"Bassiouny A.R.; Zaky A.; Fawky F.; Kandeel K.M.; Alteration of AP-endonuclease1 expression in curcumin-treated fibrotic rats. Ann Hepatol  2011,10(4),516-530","journal-title":"Ann Hepatol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MCA.0b013e32834a3817","volume":"22","author":"Nakayama N.","year":"2011","unstructured":"Nakayama N.; Nakamura T.; Okada H.; Iwaki S.; Sobel B.E.; Fujii S.; Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-\u03b2. Coron Artery Dis  2011,22(7),468-478","journal-title":"Coron Artery Dis"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"912825","DOI":"10.3389\/fphar.2022.912825","volume":"13","author":"Qi X.","year":"2022","unstructured":"Qi X.; Zheng S.; Ma M.; Lian N.; Wang H.; Chen L.; Song A.; Lu C.; Zheng S.; Jin H.; curcumol suppresses CCF-mediated hepatocyte senescence through blocking LC3B\u2013Lamin B1 interaction in alcoholic fatty liver disease. Front Pharmacol  2022,13,912825","journal-title":"Front Pharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1089\/jmf.2021.K.0098","volume":"25","author":"Lee M.","year":"2022","unstructured":"Lee M.; Nam S.H.; Yoon H.G.; Kim S.; You Y.; Choi K.C.; Lee Y.H.; Lee J.; Park J.; Jun W.; Fermented Curcuma longa L. prevents alcoholic fatty liver disease in mice by regulating CYP2E1, SREBP-1c, and PPAR- \u03b1. J Med Food  2022,25(4),456-463","journal-title":"J Med Food"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2095-4964(14)60006-6","volume":"12","author":"Nwozo S.O.","year":"2014","unstructured":"Nwozo S.O.; Osunmadewa D.A.; Oyinloye B.E.; Anti-fatty liver effects of oils from Zingiber officinale and Curcuma longa on ethanol-induced fatty liver in rats. J Integr Med  2014,12(1),59-65","journal-title":"J Integr Med"},{"key":"ref=140","first-page":"981963","volume":"2009","author":"Samuhasaneeto S.","year":"2009","unstructured":"Samuhasaneeto S.; Thong-Ngam D.; Kulaputana O.; Suyasunanont D.; Klaikeaw N.; Curcumin decreased oxidative stress, inhibited NF-kappaB activation, and improved liver pathology in ethanol-induced liver injury in rats. J Biomed Biotechnol  2009,2009,981963","journal-title":"J Biomed Biotechnol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1002\/mnfr.200700238","volume":"52","author":"L\u00f3pez-L\u00e1zaro M.","year":"2008","unstructured":"L\u00f3pez-L\u00e1zaro M.; Anticancer and carcinogenic properties of curcumin: Considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res  2008,52(S1),S103-S127","journal-title":"Mol Nutr Food Res"},{"key":"ref=142","first-page":"1","volume":"427","author":"Program N.T.","year":"1993","unstructured":"Program N.T.; NTP toxicology and carcinogenesis studies of turmeric oleoresin (CAS No. 8024-37-1)(major component 79%-85% curcumin, CAS No. 458-37-7) in F344\/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser  1993,427,1-275","journal-title":"Natl Toxicol Program Tech Rep Ser"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"6731","DOI":"10.1038\/sj.onc.1209936","volume":"25","author":"Bubici C.","year":"2006","unstructured":"Bubici C.; Papa S.; Dean K.; Franzoso G.; Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: Molecular basis and biological significance. Oncogene  2006,25(51),6731-6748","journal-title":"Oncogene"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.biopha.2016.06.036","volume":"83","author":"Zhong W.","year":"2016","unstructured":"Zhong W.; Qian K.; Xiong J.; Ma K.; Wang A.; Zou Y.; Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K\/AKT and NF-\u03baB related signaling. Biomed Pharmacother  2016,83,302-313","journal-title":"Biomed Pharmacother"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230815113921","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/219706\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230815113921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T03:15:41Z","timestamp":1743131741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/219706\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":144,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230815113921","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-05-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}